Allergy Liquid
NDC Package 81825-0007-1
Package Information
Allergy (allium cepa, ambrosia, arsenicum alb, carbo veg, euphrasia, nux vom, phosphorus, pulsatilla, sulphur, solidago) liquids is uSES: Temporarily relieves hay fever, coryza, itching and burning eyes, coughing and/or other symptoms associated with hay fever and allergies.**. This formulation utilizes a liquid delivery system. Marketed by Zorex International, this product is identified by NDC 81825-0007.
Identification & Billing
Clinical Specifications
- Allergens - [CS]
- Allergens - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Dietary Proteins - [CS]
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased IgG Production - [PE] (Physiologic Effect)
- Non-Standardized Food Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Non-Standardized Plant Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Plant Proteins - [CS]
- Seed Storage Proteins - [CS]
- Vegetable Proteins - [CS]
Regulatory & Marketing
Hierarchy Structure
- 81825 - Zorex International
- 81825-0007 - Allergy
- 81825-0007-1 - 30 mL in 1 BOTTLE, DROPPER
- 81825-0007 - Allergy
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 81825-0007-1 identifies a specific commercial package of 30 ml in 1 bottle, dropper of Allergy, a human over the counter drug labeled by Zorex International. This liquid is formulated for oral use and contains activated charcoal; ambrosia artemisiifolia whole; euphrasia stricta; onion; phosphorus; pulsatilla vulgaris whole; solidago virgaurea flowering top; strychnos nux-vomica seed; sulfur as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Zorex International on February 16, 2022. The current certification is valid through December 31, 2026.
How is this Zorex International product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 81825000701. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.